Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033

Pharmaceutical Intermediates Market 2024 – By Product (Chemical Intermediate, Bulk Drug Intermediate, Other Products), By Category (Branded Drug Intermediate, Generic Drug Intermediate), By Application (Oncology Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Metabolic Disorders Drugs, Other Applications), By End-User (Biotech And Pharma Companies, Research Institutions, Other End-Users), And By Region, Opportunities And Strategies – Global Forecast To 2033

Starting Price : $4000.00 | Pages : 326 | Published : March 2024 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN

Pharmaceutical Intermediates Market Definition

Pharmaceutical intermediates are chemical compounds that are used in the production of active pharmaceutical ingredients (APIs) or finished pharmaceutical products. These intermediates play a crucial role in the synthesis and manufacturing processes of pharmaceuticals, serving as key building blocks or transitional stages in the overall production chain. Pharmaceutical intermediates undergo chemical transformations during the manufacturing process to eventually yield the final API or drug formulation.

The pharmaceutical intermediates market consists of sales of pharmaceutical intermediates by entities (organizations, sole traders and partnerships) that manufacture these chemical compounds. These intermediates contribute significantly to the pharmaceutical industry by facilitating the efficient and cost-effective synthesis of APIs. They undergo rigorous safety and quality assessments to ensure compliance with regulatory standards.

Pharmaceutical Intermediates Market Size

The global pharmaceutical intermediates market reached a value of nearly $31,327.6 million in 2023, having grown at a compound annual growth rate (CAGR) of 4.7% since 2018. The market is expected to grow from $31,327.6 million in 2023 to $43,242.4 million in 2028 at a rate of 6.7%. The market is then expected to grow at a CAGR of 7.9% from 2028 and reach $63,245.0 million in 2033.    

Growth in the historic period resulted from an increase in pharmaceutical research and development (R&D) expenditure, strong economic growth in emerging markets, the increasing focus on personalized medicine and the growing chemical industry. Factors that negatively affected growth in the historic period was stringent regulations on approval of pharmaceutical drugs.

Going forward, the rising prevalence of chronic diseases, the increasing size of the aging population and growth of pharmaceutical manufacturing will drive the growth. Factor that could hinder the growth of the pharmaceutical intermediates market in the future include high cost of manufacturing.  

Pharmaceutical Intermediates Market Drivers

The key drivers of the pharmaceutical intermediates market include:

Rising Prevalence Of Chronic Diseases

The rise in the prevalence of chronic diseases is expected to propel the growth of the pharmaceutical intermediates market going forward. Chronic diseases refer to a sickness or condition that typically lasts three months or longer and has the potential to worsen over time. The rise in chronic diseases is mostly driven by the aging population, lifestyle changes, rapid urbanization and lack of preventive measures. Pharmaceutical intermediates play a crucial role in the development and production of medications used to manage chronic diseases. According to the United Nations, by 2030 the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic disease is expected to reach about 60% of all diseases; global burden of chronic disease refers to the financial and societal burden of diseases.  According to the National Cancer Institute (NCI) report, it was estimated that 1.7 million new cases of cancer were diagnosed in the USA in 2019 and 606,880 people are expected to die from the disease.  Therefore, the increasing number of chronic diseases is expected to generate high demand for the pharmaceutical intermediates market.

Pharmaceutical Intermediates Market Restraints

The key restraints on the pharmaceutical intermediates market include:

High Cost Of Manufacturing

The cost of manufacturing pharmaceutical ingredients can be significant, impacting the overall cost of drug production. Several factors contribute to the high cost of manufacturing pharmaceutical ingredients, particularly APIs, and this is a significant component of the overall cost of drug production. The prices of APIs can impact the cost of manufacturing finished pharmaceutical products. The development of new drugs includes many stages such as drug discovery, characterization, preclinical trials, bio-analytical testing and clinical trials. These stages involve a significant amount of investment and expenditure, yet the chance of success is low. Therefore, prolonged process of development with a high risk of failure and high manufacturing costs act as a restraining factor for the pharmaceutical ingredients market growth.

Pharmaceutical Intermediates Market Trends

Major trends shaping the pharmaceutical intermediates market include:

Innovative AI Solutions For Seamless Integration Of Drug Discovery And Synthesis

Companies in the pharmaceutical intermediates market are increasingly investing in technologies such as artificial intelligence (AI) to improve their products and services, increase productivity and reduce costs. AI is machine-based learning that makes use of human intelligence functionalities like reasoning and problem-solving abilities to obtain insights and provide useful information. Companies in the market are developing AI-based technology platforms for the manufacturing of pharmaceutical intermediates. For example, in December 2023, Merck, a US-based pharmaceutical company, launched its AIDDISON drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through Synthia retrosynthesis software application programming interface (API) integration. This innovative AI solution uses AI, machine learning and computer-aided drug design to speed up drug development. Merck’s AIDDISON platform aims to integrate drug discovery and synthesis, enabling laboratories to leverage generative AI and machine learning to identify the most suitable drug candidates and optimize chemical synthesis routes.

Innovative Product Launches To Support The Evolution Of Safe And Effective Medicines

Companies in the pharmaceutical intermediates market are focusing on launching new products to expand their product portfolio. For example, in September 2023, Colorcon, Inc., a US-based company that develops and supplies film coating systems, specialty excipients and functional packaging for the healthcare industry and provides pharmaceutical products, launched a new titanium dioxide-free moisture protection coating for pharmaceutical tablets. This innovative TiO2-free film coating is designed to mitigate the challenges of moisture-sensitive actives in pharmaceutical tablets. The launch of this titanium dioxide-free moisture protection coating is in response to the growing demand for pharmaceutical intermediates and the need for innovative solutions in the pharmaceutical industry.  Further, in October 2023, Clariant, a sustainability-focused specialty chemicals company, announced the launch of three new VitiPure® excipients at CPHI Barcelona to support the evolution of safe and effective medicines. These excipients are designed to allow for a multitude of active pharmaceutical ingredient (API) formulations and administration routes, even for sensitive ones, such as mRNA vaccines and biologic medications, establishing Clariant as a one-stop-shop solution provider to the industry. The new range of excipients is aimed at improving the stability and solubility of APIs, addressing the market's growing trend for high-purity ingredients.

Opportunities And Recommendations In The Pharmaceutical Intermediates Market

Opportunities – The top opportunities in the pharmaceutical intermediates market segmented by product will arise in the bulk drug intermediate segment, which will gain $5,754.4 million of global annual sales by 2028. The top opportunities in the pharmaceutical intermediates market segmented by category will arise in the generic drug intermediate segment, which will gain $7,733.2 million of global annual sales by 2028. The top opportunities in the pharmaceutical intermediates market segmented by application will arise in the oncology drugs segment, which will gain $2,972.7 million of global annual sales by 2028. The top opportunities in the pharmaceutical intermediates market segmented by end-user will arise in the biotech and pharma companies segment, which will gain $9,431.3 million of global annual sales by 2028. The pharmaceutical intermediates market size will gain the most in the USA at $3,525.1 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the pharmaceutical intermediates companies to focus on integrating ai technologies for enhanced pharmaceutical intermediates, focus on diversifying product portfolio for enhanced market presence, focus on strategic expansion of production facilities, focus on green chemistry for sustainable growth, focus on diversifying product portfolio for enhanced market presence, focus on strategic expansion of production facilities, focus on green chemistry for sustainable growth, focus on bulk drug intermediates for sustained growth, focus on generic drug intermediates, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships, focus on diversified distribution channels for market expansion, provide competitively priced offerings, focus on strategic pricing for market competitiveness, participate in trade shows and events, continue to use B2B promotions, focus on integrated promotion for market visibility, focus on metabolic disorders and oncology drugs application segments, focus on biotech and pharma companies for robust growth.

Pharmaceutical Intermediates Market Segmentation

The pharmaceutical intermediates market is segmented by product, by category, by application and by end-user.

By Product –
The pharmaceutical intermediates market is segmented by product into:
    • a) Chemical Intermediate
    • b) Bulk Drug Intermediate
    • c) Other Products
The bulk drug intermediate market was the largest segment of the pharmaceutical intermediates market segmented by product, accounting for 48.9% or $15,330.8 million of the total in 2023. Going forward, the other products segment is expected to be the fastest growing segment in the pharmaceutical intermediates market segmented by product, at a CAGR of 7.3% during 2023-2028.

By Category –
The pharmaceutical intermediates market is segmented by category into:
    • a) Branded Drug Intermediate
    • b) Generic Drug Intermediate
The generic drug intermediate market was the largest segment of the pharmaceutical intermediates market segmented by category, accounting for 60.0% or $18,796.6 million of the total in 2023. Going forward, it is expected to be the fastest growing segment in the pharmaceutical intermediates market segmented by category, at a CAGR of 7.1% during 2023-2028.

By Application –
The pharmaceutical intermediates market is segmented by application into:
    • a) Oncology Drugs
    • b) Anti-Infective Drugs
    • c) Central Nervous System Drugs
    • d) Respiratory Diseases Drugs
    • e) Cardiovascular Drugs
    • f) Musculoskeletal Disorders Drugs
    • g) Metabolic Disorders Drugs
    • h) Other Applications
The other applications market was the largest segment of the pharmaceutical intermediates market segmented by application, accounting for 19.2% or $6,027.0 million of the total in 2023. Going forward, the metabolic disorders drugs segment is expected to be the fastest growing segment in the pharmaceutical intermediates market segmented by application, at a CAGR of 9.1% during 2023-2028.

By End-User –
The pharmaceutical intermediates market is segmented by end-user into:
    • a) Biotech And Pharma Companies
    • b) Research Institutions
    • c) Other End-Users
The biotech and pharma companies market was the largest segment of the pharmaceutical intermediates market segmented by end-user, accounting for 81.3% or $25,466.3 million of the total in 2023. Going forward, the research institutions segment is expected to be the fastest growing segment in the pharmaceutical intermediates market segmented by end-user, at a CAGR of 7.9% during 2023-2028.

By Geography - The pharmaceutical intermediates market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the pharmaceutical intermediates market, accounting for 40.3% or $26,076.2 million of the total in 2023. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the pharmaceutical intermediates market will be Asia-Pacific and North America where growth will be at CAGRs of 33.9% and 32.5% respectively. These will be followed by Western Europe and South America where the markets are expected to grow at CAGRs of 31.7% and 25.4% respectively.

Pharmaceutical Intermediates Market Competitive Landscape

Major Competitors are:

  • BASF SE
  • Evonik Industries AG
  • Pfizer Inc
  • Arkema Inc
  • Koninklijke DSM N.V.
  • Other Competitors Include:

  • Cambrex Corporation
  • Lianhe Chemical Technology Co Ltd
  • Ercros, S.A.
  • Lonza Group AG
  • Codexis, Inc
  • Kuraray Co., Ltd
  • Actylis
  • Vertellus Holdings LLC
  • Hikal Ltd
  • WeylChem International GmbH
  • SUAN FARMA S.A.U
  • Chemcon Speciality Chemicals Limited
  • Interchem
  • Midas Pharma GmbH.
  • A. R. Life Sciences Pvt. Ltd.
  • Divi's Laboratories Limited
  • Sarex Overseas
  • Anupam Rasayan India Ltd
  • Sinopharm
  • Fosun Pharma
  • CSPC Pharmaceutical Group
  • Jiangsu Hengrui Medicine
  • Zhejiang Hisun Pharmaceutical
  • Guangzhou Pharmaceuticals
  • Minakem
  • Inabata France S.A.S
  • Biophore India Pharmaceuticals Pvt Ltd
  • Century Pharmaceuticals
  • Centrient Pharmaceuticals
  • Fermion Oy
  • Noramco
  • Merck KGaA
  • Future Science Group
  • Polska Grupa Farmaceutyczna
  • Polpharma
  • Katren
  • R-Pharm
  • Pharmkomplekt
  • Thermo Fisher Scientific Inc.
  • Aceto Corp
  • Hovione
  • Inter Chem Trading Corp.
  • Dyadic International, Inc.
  • Willow Biosciences Inc
  • Seqens International SAS
  • Snapdragon Chemistry, Inc
  • Piramal Pharma Solutions
  • Ache Laboratórios Farmacêuticos S.A.
  • Blanver Farmoquímica e Farmacêutica S.A
  • Prati-Donaduzzi
  • União Química Farmacêutica Nacional S.A
  • Laboratorios Richmond S.A.C.I.F.
  • Bago S.A.
  • Elea Laboratories S.A.C.I. y F.
  • Gador S.A.
  • Interpharma Corporation
  • Globalpharma
  • Seqens International SAS
  • Snapdragon Chemistry, Inc
  • Seqens International SAS
  • Snapdragon Chemistry, Inc
    1. Table Of Contents

      1 Executive Summary

      1.1 Pharmaceutical Intermediates – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Pharmaceutical Intermediates Market Definition And Segmentations

      6.4 Market Segmentation By Product

      6.4.1 Chemical Intermediate

      6.4.2 Bulk Drug Intermediate

      6.4.3 Other Products

      6.5 Market Segmentation By Category

      6.5.1 Branded Drug Intermediate

      6.5.2 Generic Drug Intermediate

      6.6 Market Segmentation By Application

      6.6.1 Oncology Drugs

      6.6.2 Anti-Infective Drugs

      6.6.3 Central Nervous System Drugs

      6.6.4 Respiratory Diseases Drugs

      6.6.5 Cardiovascular Drugs

      6.6.6 Musculoskeletal Disorders Drugs

      6.6.7 Metabolic Disorders Drugs

      6.6.8 Other Applications

      6.7 Market Segmentation By End-User

      6.7.1 Biotech And Pharma Companies

      6.7.2 Research Institutions

      6.7.3 Other End-Users

      7 Major Market Trends

      7.1 Innovative AI Solutions For Seamless Integration Of Drug Discovery And Synthesis

      7.2 Strategic Partnerships And Acquisitions Among Market Players To Drive Innovation In The Market

      7.3 Innovative Product Launches To Support The Evolution Of Safe And Effective Medicines

      7.4 Focus On Production Facility Expansions

      7.5 Quick Response (QR) Code Labelling To Track All Drug-Related Information

      7.6 Focus On Green Chemistry To Reduce The Environmental Impact Of Synthetic Chemistry

      8 Pharmaceutical Intermediates Market - Macro Economic Scenario

      8.1 COVID-19 Impact On The Pharmaceutical Intermediates Market

      8.2 Impact Of The War In Ukraine On The Pharmaceutical Intermediates Market

      8.3 Impact Of High Inflation On The Pharmaceutical Intermediates Market

      9 Global Market Size and Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

      9.2.1 Market Drivers 2018 – 2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      10 Global Pharmaceutical Intermediates Market Segmentation

      10.1 Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.2 Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.3 Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.4 Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11 Pharmaceutical Intermediates Market, Regional and Country Analysis

      11.1 Global Pharmaceutical Intermediates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11.2 Global Pharmaceutical Intermediates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.2 Market Overview

      12.2.1 Region Information

      12.2.2 Market Information

      12.2.3 Background Information

      12.2.4 Government Initiatives

      12.2.5 Regulations

      12.2.6 Regulatory Bodies

      12.2.7 Major Associations

      12.2.8 Taxes Levied

      12.2.9 Corporate Tax Structure

      12.2.10 Investments

      12.2.11 Major Companies

      12.3 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.4 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.5 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.6 Asia-Pacific Pharmaceutical Intermediates Market: Country Analysis

      12.7 China Market

      12.8 Summary

      12.9 Market Overview

      12.9.1 Country Information

      12.9.2 Market Information

      12.9.3 Background Information

      12.9.4 Government Initiatives

      12.9.5 Regulations

      12.9.6 Regulatory Bodies

      12.9.7 Major Associations

      12.9.8 Taxes Levied

      12.9.9 Corporate Tax Structure

      12.9.10 Investments

      12.9.11 Major Companies

      12.1 China Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.11 China Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.12 China Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.13 India Market

      12.14 India Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.15 India Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.16 India Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.17 Japan Market

      12.18 Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.19 Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.2 Japan Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.21 Australia Market

      12.22 Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.23 Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.24 Australia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.25 Indonesia Market

      12.26 Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.27 Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.28 Indonesia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.29 South Korea Market

      12.3 South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.31 South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.32 South Korea Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.2 Market Overview

      13.2.1 Region Information

      13.2.2 Market Information

      13.2.3 Background Information

      13.2.4 Government Initiatives

      13.2.5 Regulations

      13.2.6 Regulatory Bodies

      13.2.7 Major Associations

      13.2.8 Taxes Levied

      13.2.9 Corporate Tax Structure

      13.2.10 Investments

      13.2.11 Major Companies

      13.3 Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.4 Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.5 Western Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.6 Western Europe Pharmaceutical Intermediates Market: Country Analysis

      13.7 UK Market

      13.8 UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.9 UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.1 UK Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.11 Germany Market

      13.12 Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.13 Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.14 Germany Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.15 France Market

      13.16 France Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.17 France Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.18 France Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.19 Italy Market

      13.2 Italy Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.21 Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.22 Italy Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.23 Spain Market

      13.24 Spain Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.25 Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.26 Spain Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.2 Market Overview

      14.2.1 Region Information

      14.2.2 Market Information

      14.2.3 Background Information

      14.2.4 Government Initiatives

      14.2.5 Regulations

      14.2.6 Regulatory Bodies

      14.2.7 Major Associations

      14.2.8 Taxes Levied

      14.2.9 Corporate Tax Structure

      14.2.10 Investments

      14.2.11 Major Companies

      14.3 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.4 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.5 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.6 Eastern Europe Pharmaceutical Intermediates Market: Country Analysis

      14.7 Russia Market

      14.8 Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.9 Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.1 Russia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.2 Market Overview

      15.2.1 Region Information

      15.2.2 Market Information

      15.2.3 Background Information

      15.2.4 Government Initiatives

      15.2.5 Regulations

      15.2.6 Regulatory Bodies

      15.2.7 Major Associations

      15.2.8 Taxes Levied

      15.2.9 Corporate Tax Structure

      15.2.10 Investments

      15.2.11 Major Companies

      15.3 North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.4 North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.5 North America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.6 North America Pharmaceutical Intermediates Market: Country Analysis

      15.7 USA Market

      15.8 Summary

      15.9 Market Overview

      15.9.1 Country Information

      15.9.2 Market Information

      15.9.3 Background Information

      15.9.4 Government Initiatives

      15.9.5 Regulations

      15.9.6 Regulatory Bodies

      15.9.7 Major Associations

      15.9.8 Taxes Levied

      15.9.9 Corporate Tax Structure

      15.9.10 Investments

      15.9.11 Major Companies

      15.1 USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.11 USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.12 USA Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.13 Canada Market

      15.14 Canada Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.15 Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.16 Canada Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.2 Market Overview

      16.2.1 Region Information

      16.2.2 Market Information

      16.2.3 Background Information

      16.2.4 Government Initiatives

      16.2.5 Regulations

      16.2.6 Regulatory Bodies

      16.2.7 Major Associations

      16.2.8 Taxes Levied

      16.2.9 Corporate Tax Structure

      16.2.10 Investments

      16.2.11 Major Companies

      16.3 South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.4 South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.5 South America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.6 South America Pharmaceutical Intermediates Market: Country Analysis

      16.7 Brazil Market

      16.8 Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.9 Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.1 Brazil Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.2 Market Overview

      17.2.1 Region Information

      17.2.2 Market Information

      17.2.3 Background Information

      17.2.4 Government Initiatives

      17.2.5 Regulations

      17.2.6 Regulatory Bodies

      17.2.7 Major Associations

      17.2.8 Taxes Levied

      17.2.9 Corporate Tax Structure

      17.2.10 Investments

      17.2.11 Major Companies

      17.3 Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.4 Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.5 Middle East Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.2 Market Overview

      18.2.1 Region Information

      18.2.2 Market Information

      18.2.3 Background Information

      18.2.4 Government Initiatives

      18.2.5 Regulations

      18.2.6 Regulatory Bodies

      18.2.7 Major Associations

      18.2.8 Taxes Levied

      18.2.9 Corporate Tax Structure

      18.2.10 Investments

      18.2.11 Major Companies

      18.3 Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.4 Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.5 Africa Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      19 Competitive Landscape and Company Profiles

      19.1 Company Profiles

      19.2 BASF SE

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial Overview

      19.3 Evonik Industries AG

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Business Strategy

      19.3.4 Financial Overview

      19.4 Pfizer Inc

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 Arkema S.A.

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Business Strategy

      19.5.4 Financial Overview

      19.6 Koninklijke DSM N.V.

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial performance

      20 Other Major And Innovative Companies

      20.1 Cambrex Corporation

      20.1.1 Company Overview

      20.1.2 Products And Services

      20.1.3 Business Strategy

      20.2 Lianhe Chemical Technology Co Ltd

      20.2.1 Company Overview

      20.2.2 Products And Services

      20.3 Ercros, S.A.

      20.3.1 Company Overview

      20.3.2 Products And Services

      20.3.3 Business Strategy

      20.4 Lonza Group AG

      20.4.1 Company Overview

      20.4.2 Products And Services

      20.4.3 1.4.3 Business Strategy

      20.5 Codexis, Inc

      20.5.1 Company Overview

      20.5.2 Products And Services

      20.5.3 Business Strategy

      20.6 Actylis

      20.6.1 Company Overview

      20.6.2 Products And Services

      20.6.3 Business Strategy

      20.7 Kuraray Co., Ltd

      20.7.1 Company Overview

      20.7.2 Products And Services

      20.8 Vertellus Holdings LLC

      20.8.1 Company Overview

      20.8.2 Products And Services

      20.9 Hikal Ltd

      20.9.1 Company Overview

      20.9.2 Products And Services

      20.1 WeylChem International GmbH

      20.10.1 Company Overview

      20.10.2 Products And Services

      20.10.3 Business Strategy

      21 Competitive Benchmarking

      22 Competitive Dashboard

      23 Key Mergers And Acquisitions

      23.1 Hovione Acquired ExtremoChem

      23.2 Noramco Acquired The Cambrex Drug Product Business Unit

      23.3 Harmony Biosciences Acquired Zynerba Pharmaceuticals

      23.4 UBE Acquired API Corporation

      23.5 Cambrex Acquired Snapdragon Chemistry

      23.6 Sekhmet Pharmaventures Acquired Optimus Drugs

      23.7 SK Capital Partners Acquired A Majority Shareholding Of SEQENS

      23.8 Aceto Corporation Acquired Cascade Chemistry

      23.9 Wavelength Pharmaceuticals Acquired Vanamali Organics

      24 Opportunities And Strategies

      24.1 Global Pharmaceutical Intermediates Market In 2028 – Countries Offering Most New Opportunities

      24.2 Global Pharmaceutical Intermediates Market In 2028 – Segments Offering Most New Opportunities

      24.3 Global Pharmaceutical Intermediates Market In 2028 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 Pharmaceutical Intermediates Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global Pharmaceutical Intermediates Market, Historic, 2018 – 2023, $ Million
    • Table 2: Global Pharmaceutical Intermediates Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Table 3: Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 4: Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 5: Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 6: Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 7: Global Pharmaceutical Intermediates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 8: Global Pharmaceutical Intermediates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 9: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
    • Table 10:  Asia-Pacific Population, By Country, 2018-2028, Millions
    • Table 11: Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 12: Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 13: Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 14: China GDP Per Capita, 2018-2023, $
    • Table 15:  China Population, 2018-2028, Millions
    • Table 16: China Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 17: China Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 18: China Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 19: India Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 20: India Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 21: India Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 22: Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 23: Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 24: Japan Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 25: Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 26: Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 27: Australia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 28: Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 29: Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 30: Indonesia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 31: South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 32: South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 33: South Korea Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 34: Western Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 35:  Western Europe Population, By Country, 2018-2028, Millions
    • Table 36: Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 37: Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 38: Western Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 39: UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 40: UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 41: UK Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 42: Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 43: Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 44: Germany Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 45: France Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 46: France Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 47: France Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 48: Italy Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 49: Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 50: Italy Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 51: Spain Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 52: Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 53: Spain Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 54: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 55:  Eastern Europe Population, By Country, 2018-2028, Millions
    • Table 56: Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 57: Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 58: Eastern Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 59: Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 60: Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 61: Russia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 62: North America GDP Per Capita, By Country, 2018-2023, $
    • Table 63:  North America Population, By Country, 2018-2028, Millions
    • Table 64: North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 65: North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 66: North America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 67: USA GDP Per Capita, 2018-2023, $
    • Table 68:  USA Population, 2018-2028, Millions
    • Table 69: USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 70: USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 71: USA Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 72: Canada Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 73: Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 74: Canada Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 75: South America GDP Per Capita, By Country, 2018-2023, $
    • Table 76:  South America Population, By Country, 2018-2028, Millions
    • Table 77: South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 78: South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 79: South America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 80: Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 81: Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 82: Brazil Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 83: Middle East GDP Per Capita, By Country, 2018-2023, $
    • Table 84:  Middle East Population, By Country, 2018-2028, Millions
    • Table 85: Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 86: Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 87: Middle East Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 88: Africa GDP Per Capita, By Country, 2018-2023, $
    • Table 89:  Africa Population, By Country, 2018-2028, Millions
    • Table 90: Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 91: Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 92: Africa Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 93: Global Pharmaceutical Intermediates Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Table 94: BASF SE – Financial Overview, 2018 – 2022, $ Billion
    • Table 95: Evonik Industries AG – Financial Overview, 2018 – 2022, $ Billion
    • Table 96: Pfizer Inc – Financial Overview, 2018 – 2022, $ Billion
    • Table 97: Arkema S.A. – Financial Overview, 2018 – 2022, $ Billion
    • Table 98: Koninklijke DSM N.V. – Financial performance, 2018 – 2022, $ Billion
    • Table 99: Pharmaceutical Intermediates Market, Competitive Benchmarking (In USD Millions)
    • Table 100: Pharmaceutical Intermediates Market, Competitive Dashboard
    • Table 101: Global Pharmaceutical Intermediates Market Size Gain ($ Million), 2023 – 2028, By Country
    • Table 102: Global Pharmaceutical Intermediates Market Size Gain ($ Million), Segmentation By Product, 2023 – 2028
    • Table 103: Global Pharmaceutical Intermediates Market Size Gain ($ Million), Segmentation By Category, 2023 – 2028
    • Table 104: Global Pharmaceutical Intermediates Market Size Gain ($ Million), Segmentation By Application, 2023 – 2028
    • Table 105: Global Pharmaceutical Intermediates Market Size Gain ($ Million), Segmentation By End-User, 2023 – 2028
    • Table 106: Pharmaceutical Intermediates Market Data Sources

    List Of Figures

      Figure 1: Global Pharmaceutical Intermediates Market Segmentation By Product
    • Figure 2: Global Pharmaceutical Intermediates Market Segmentation By Category
    • Figure 3: Global Pharmaceutical Intermediates Market Segmentation By Application
    • Figure 4: Global Pharmaceutical Intermediates Market Segmentation By End-User
    • Figure 5: Global Pharmaceutical Intermediates Market, Historic, 2018 – 2023, $ Million
    • Figure 6: Global Pharmaceutical Intermediates Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Figure 7: Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 8: Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 9: Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 10: Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 11: Global Pharmaceutical Intermediates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 12: Global Pharmaceutical Intermediates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 13: Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 14: Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 15: Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 16: China Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 17: China Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 18: China Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 19: India Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 20: India Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 21: India Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 22: Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 23: Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 24: Japan Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 25: Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 26: Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 27: Australia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 28: Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 29: Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 30: Indonesia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 31: South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 32: South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 33: South Korea Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 34: Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 35: Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 36: Western Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 37: UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 38: UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 39: UK Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 40: Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 41: Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 42: Germany Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 43: France Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 44: France Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 45: France Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 46: Italy Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 47: Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 48: Italy Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 49: Spain Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 50: Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 51: Spain Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 52: Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 53: Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 54: Eastern Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 55: Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 56: Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 57: Russia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 58: North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 59: North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 60: North America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 61: USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 62: USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 63: USA Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 64: Canada Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 65: Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 66: Canada Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 67: South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 68: South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 69: South America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 70: Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 71: Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 72: Brazil Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 73: Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 74: Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 75: Middle East Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 76: Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 77: Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 78: Africa Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 79: Global Pharmaceutical Intermediates Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Figure 80: BASF SE – Financial Overview, 2018 – 2022, $ Billion
    • Figure 81: Evonik Industries AG – Financial Overview, 2018 – 2022, $ Billion
    • Figure 82: Pfizer Inc – Financial Overview, 2018 – 2022, $ Billion
    • Figure 83: Arkema S.A. – Financial Overview, 2018 – 2022, $ Billion
    • Figure 84: Koninklijke DSM N.V. – Financial performance, 2018 – 2022, $ Billion
    • Figure 85: Geographic Regions Covered
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report